Category Archives: Science

You Have to Know Your Genes Better than Makes of Cars

FOXO

Figure 1. In the absence of insulin or growth factors, FOXO transcription factors are located in the nucleus, where they specify target gene expression (see text for details).

Knowing what kind of genes are involved in the main biological processes is much more relevant to your life than which car is faster, Porsche or Jaguar. And I’m not talking about dangerous driving here. I am talking about the crucial information about the genes that govern your longevity. You have to know what they are, what they do, what happens to them during aging and what are the ways to make them work better, towards keeping you young for a longer time. I am reprinting the text of the article written by Dr. Matthew Carter and Dr. Anne Brunet from Stanford University. I let myself explain some of the biological terms in brackets to make this beautifully written story of one gene a bit simpler. This is a must-read.

FOXO transcription factors 

What are they? FOXO proteins are a subgroup of the Forkhead family of transcription factors (proteins that can bind to DNA and “switch on” other genes) . This family is characterized by a conserved DNA-binding domain (the ‘Forkhead box’, or FOX) and comprises more than 100 members in humans, classified from FOXA to FOXR on the basis of sequence similarity. These proteins participate in very diverse functions: for example, FOXE3 is necessary for proper eye development, while FOXP2 plays a role in language acquisition. Members of class ‘O’ share the characteristic of being regulated by the insulin/PI3K/Akt signaling pathway (a chain of reactions within a cell that is the response to a signaling molecule attaching to a receptor on the surface of the cell).

How did this family get named ‘Forkhead’? Forkhead, the founding member of the entire family (now classified as FOXA), was originally identified in Drosophila as a gene whose mutation resulted in ectopic (meaning unusual) head structures that looked like a fork. Forkhead proteins are also sometimes referred to as ‘winged helix’ proteins because X-ray crystallography revealed that the DNA-binding domain features a 3D structure with three α-helices flanked by two characteristic loops that resemble butterfly wings.

How many FOXOs are there? In invertebrates, there is only one FOXO gene, termed daf-16 in the worm and dFOXO in the fly. In mammals, there are four FOXO genes, FOXO1, 3, 4, and 6.

Hey, what about FOXO2 and FOXO5? FOXO2 is identical to FOXO3 (a.k.a. FOXO3a, as opposed to FOXO3b, a pseudogene, dysfunctional relative of a gene, unable to produce protein). FOXO5 is the fish ortholog (genetic analog) of FOXO3.

FOX hunting… FOXO genes were first identified in humans because three family members (1, 3, and 4) were found at chromosomal translocations (errors) in rhabdomyosarcomas and acute myeloid leukemias. Just after FOXO factors were identified in human tumor cells, the crucial role of DAF-16 in organismal longevity was discovered in worms. DAF-16 activity was shown to be negatively regulated by the insulin/PI3K/Akt signaling pathway (the pathway that provides cellular response to insulin). Subsequent experiments in mammalian cells showed that mammalian FOXO proteins were directly phosphorylated (a phosphate was bound) and inhibited (suppressed) by Akt in response to insulin/ growth factor stimulation. Thus, FOXO factors are evolutionarily conserved mediators of insulin and growth factor signaling (meaning they are present in the majority of animals throughout the evolutionary tree from simple species like worms to humans).

Why are they important? FOXO transcription factors are at the interface of crucial cellular processes, orchestrating programs of gene expression (production of proteins) that regulate apoptosis (cellular programmed death), cell-cycle progression, and oxidative- stress resistance (Figure 1). For example, FOXO factors can initiate apoptosis by activating transcription of FasL, the ligand for the Fas-dependent cell-death pathway, and by activating the pro-apoptotic Bcl-2 family member Bim. Alternatively, FOXO factors can promote cell-cycle arrest (it’s when the cell can’t continue its life path, stops dividing); for example, FOXO factors upregulate (increase production of dependent proteins) the cell-cycle inhibitor p27kip1 to induce G1 arrest (a point of time in the cell-cycle when the cell needs to check whether its DNA has no errors, and if it doesn’t, it can go on to the next stage of development) or GADD45 to induce G2 arrest (point of time when the cell checks if it has any DNA errors after replication, and if it doesn’t it can start mitosis). FOXO factors are also involved in stress resistance via upregulation of catalase and MnSOD, two enzymes involved in the detoxification of reactive oxygen species. Additionally, FOXO factors facilitate the repair of damaged DNA by upregulating genes, such as GADD45 and DDB1. Other FOXO target genes have been shown to play a role in glucose metabolism, cellular differentiation, muscle atrophy, and even energy homeostasis.

How are they regulated? FOXO proteins are tightly regulated to ensure that transcription (first step in protein synthesis) of specific target genes is responsive to environmental conditions. A major form of regulation is Akt-mediated phosphorylation of FOXO in response to insulin or growth factors (Figure 1). Phosphorylation at three conserved residues results in the export of FOXO factors from the nucleus to the cytoplasm, thereby inhibiting FOXO-dependent transcription. FOXO proteins are also phosphorylated by other protein kinases, including JNK or Mst1, which phosphorylate FOXO under conditions of oxidative stress. This phosphorylation causes the translocation of FOXO from the cytoplasm to the nucleus, thus opposing Akt’s action. In addition to being post-translationally modified by phosphorylation, FOXO proteins also bind to co-activator or co-repressor complexes and become acetylated or deacetylated (process of adding or removing the acetyl group). For example, the deacetylase SIRT1 increases FOXO DNA-binding ability by deacetylating FOXO in response to oxidative stress. FOXO proteins are also monoubiquitinated (added one ubiquitin group) under conditions of oxidative stress and this increases transcriptional activity. Finally, FOXO proteins can also be polyubiquitinated and targeted for protein degradation. The unique phosphorylation, acetylation, and ubiquitination status of FOXO under specific environmental conditions may provide specificity in the regulation of subsets of FOXO target genes.

What is the role of FOXO in longevity? FOXO factors have been shown to prolong lifespan in invertebrates. The worm orthologue, DAF-16, activates a program of genes that extend longevity by promoting resistance to oxidative stress, pathogens, and damage to protein structure. Mutations in the insulin receptor or PI3K extend longevity up to threefold, and this extension is reverted when daf-16 is mutated. In flies, overexpression of dFOXO is sufficient to increase longevity. The role of FOXO factors in mammalian longevity is currently being explored. Mice that are deficient for either the insulin receptor or the insulin-like growth factor receptor-1 can live up to 30% longer than wild-type mice, suggesting that FOXO factors could be involved in mammalian longevity. Furthermore, FOXO target genes involved in stress resistance are conserved between invertebrates and mammals, suggesting that the function of FOXO in organismal stress resistance and longevity is evolutionarily conserved.

Isn’t it strange that FOXO could induce both stress resistance and cell death? The regulation of stress-resistance genes and pro-apoptotic genes by FOXO is not necessarily a paradox. FOXO factors may orchestrate different patterns of gene expression based on the intensity of the stimulus, perhaps activating stress-resistance genes under mild conditions but pro-apoptotic genes when the intensity of stress stimuli increases beyond a certain threshold. It is also possible that FOXO factors regulate different genes in different cell types, causing apoptosis in some cells (e.g. neurons, lymphocytes) while promoting survival in others. Importantly, the induction of apoptosis by FOXO may cause the death of damaged or abnormal cells, therefore benefiting the longevity of the entire organism.

Is there a connection between FOXO and cancer? Because FOXO proteins were originally identified in human tumors, and because they play an important role in cell-cycle arrest, DNA repair, and apoptosis — cell functions that go awry in cancer — the FOXO family is thought to coordinate the balance between longevity and tumor suppression. Consistent with this idea, in certain breast cancers, FOXO3 is sequestered in the cytoplasm and inactivated. Expression of active forms of FOXO in tumor cells prevents tumor growth in vivo. Additionally, protein partners of FOXO, such as p53 and SMAD transcription factors, are tumor suppressors. Investigating the ensemble of FOXO protein partners will provide insight into the connection between aging and cancer.

Can you live without FOXO? It depends if you are a worm, a fly, or a mammal. Worms lacking daf-16 or flies lacking dFOXO are viable but do not show an increase in lifespan following mutations in the insulin/PI3K/Akt pathway. FoxO1-null mice (mutants that have no FoxO1 gene) die at embryonic day 10.5 from defects in angiogenesis. FoxO3- and FoxO4-null mice have also been produced and are viable: FoxO3-null mice exhibit an age-dependent infertility in females, while FoxO4-null mice have no apparent phenotype. FoxO6-null mice are currently being generated. The four mammalian isoforms (different form of a protein) may have both distinct and overlapping functions, and compensation of one member by another may mask the function of individual FOXOs. Investigating the role of FOXO factors in longevity and tumor suppression will require more complex mouse models in which multiple FoxO genes are deleted.

What remains to be explored? More FOXO target genes remain to be discovered, as do regulators of FOXO function. An exciting area of future exploration will be to determine how FOXO factors mediate cell non-autonomous processes in the entire organism. The recent discovery that FOXO can upregulate neuropeptides in the hypothalamus suggests that FOXO can regulate animal behavior, and future studies will elucidate how hormones and neuronal signaling cause FOXO- dependent transcription of target genes that affect the entire organism.

2 Comments

Filed under Genetics

Judy Campisi Shares Her Thoughts about Aging in Scientific American

Judith Campisi, professor at the Buck Institute for Research on Aging and senior scientist at the Lawrence Berkeley National Laboratory

One of the questions in the Scientific American interview of one of the top gerontologists, Judy Campisi, is really intriguing. Here’s the question and Dr. Campisi’s answer:

What would you say is one of the biggest mysteries of aging research?
Why do organisms with remarkable genetic similarity have sometimes remarkable differences in life span?

We know that for the most part, many of the processes that go on in the human body also go on in yeast and mice. Yet, yeast live a few days, a mouse lives about three years, and people live for decades. We really do not know what evolution has done to take basically the same genes and produce different life spans.

I think this is probably the most important question in aging research, because answering it may lead to those mysteries, and subsequently, clues to the problem of aging that we are now missing. What are those odd lifespans/metabolic patters/gene expression profiles/regenerative capabilities that certain animals have, but others don’t? What is that scientists dream of investigating, but can’t because of lack of funding and low chances of getting funds for such unconventional studies?

What mysteries of aging do you know?

1 Comment

Filed under Science

David Gems – Fluorescence Makes Death Visible in Worms

Enjoy this interesting talk by Dr. David Gems, PhD, Reader in the Biology of aging at the University College London.

A major focus of current work in Dr. Gems’ laboratory is understanding the genes and biochemical processes by which reduced insulin/IGF-1 signalling and dietary restriction increase lifespan. Other interests include sex differences in the biology of aging, evolutionary conservation of mechanisms of aging, and bioethical implications of aging research.

Leave a Comment

Filed under Conference

Alexander Vaiserman – Hormesis: A Kind of Epigenetic Phenomoenon?

Watch Dr. Alexander Vaiserman, MD, PhD, Kiev Institute of Gerontology, talk about hormesis and its role in aging and epigenetics.

1 Comment

Filed under Conference

Holly Brown-Borg – Growth Hormone and Aging: Does DNA Methylation Play a Role?

Here’s a talk by Dr. Holly Brown-Borg, PhD, Professor, University of North Dakota, about the role of DNA methylation in defense mechanisms of Ames dwarf mice. Growth hormone is definitely not an anti-aging, but a pro-aging drug. Watch the talk and learn at least a couple of reasons why.

Leave a Comment

Filed under Conference

Benjamin Button Jellyfish

immortal jellyfish

I enjoy reading the New York Times so much. Especially when they write about various aspects of aging. This article got my attention, because is even better, it’s about immortality and fighting aging. You have probably heard about the immortal  jellyfish, Turritopsis dohrnii, that instead of dying goes back in time and renews itself to become young again. It’s fascinating. It could give us the clues to make a human being immortal, however I quote:

 You might expect that, having learned of the existence of immortal life, man would dedicate colossal resources to learning how the immortal jellyfish performs its trick. You might expect that biotech multinationals would vie to copyright its genome; that a vast coalition of research scientists would seek to determine the mechanisms by which its cells aged in reverse; that pharmaceutical firms would try to appropriate its lessons for the purposes of human medicine; that governments would broker international accords to govern the future use of rejuvenating technology. But none of this happened.

And this is not the most surprising thing! Do you know how many researchers in the world culture the immortal jellyfish in a lab? Just one. I found this really shocking. There’s only one guy, a Japanese professor Dr. Shin Kubota, who has been keeping a population of  Turritopsis dohrnii in a lab, carefully looking after them and studying them. I believe he is one of the most amazing researchers in the world, because he studies the jelly fish to solve the problem of aging and become immortal. I quote him:

The immortal medusa is the most miraculous species in the entire animal kingdom, I believe it will be easy to solve the mystery of immortality and apply ultimate life to human beings.

That’s the spirit! I believe Dr. Kubota needs all the help in the world to figure out what it is exactly that makes the immortal jelly fish be able to reverse its age backwards. It’s such a shame that he has got no money and no help at all to conduct this kind of research. I understood from the article that other than funding Dr. Kubota needs a molecular biologist and a geneticist to collaborate with to decipher those rejuvenation mechanisms. Anyone interested? Any volunteers? Do I need to say that this is probably the most important research in the history of mankind?

5 Comments

Filed under Mechanisms of aging

Google Wants to Fund Radical Life Extension Startups

I think you’ve all read the news that Google is to fund radical life extension, cryogenics and nanotechnology. My thoughts about it:

1. I love the sound of it, obviously “We look for entrepreneurs with a healthy disregard for the impossible.” Ah, it’s it beautiful? However, I don’t want to be too happy too prematurely. Even though Google Ventures invests in 23andme and Foundation Medicine, which is not a bad start in the right direction, but we’ll see how it goes and what companies they will choose to support in the future.

2. How do they make sure they won’t invest in the swindlers that crowded the anti-aging field? I wonder how the choosing and verification process is organized and who the experts in radical life extension field are.

3. Why cryogenics, but not cryonics or cryopreservation? Or do they seriously mean freezing metals and other materials? How is that going to save billions of lives?

4. And my major concern – what about basic science? I do realize I writing about a venture fund. However, I believe without investing in the fundamental science behind radical life extension, there will be no radical life extension, but only the frauds who offer snaik oil and claim that it heals all diseases including aging. Investors love simple solutions. There can be no simple solution in radical life extension. We know quite a few examples when investors got severely disappointed when they fell under the spell of simplicity and gave money for a pill to stop aging. Obviously, there can be no single pill, so the investors fell like fools and shut the door of opportunity for good projects. I am very concerned that something similar might happen to Google Ventures. In order to prevent this situation Google Ventures should pay a lot of attention to basic research into the mechanisms of aging and have a well educated and experienced team of experts who can distinguish bad projects from the good ones.

5. Google Ventures has a great potential to improve the attitude to radical life extension and cryonics. By choosing these fields Google sets a terrific example for other companies and agencies, as well as for the public, to pay attention to these topics. This can very quite helpful in creating the positive image of life extension, because everyone knows that Google is no fool and won’t invest in useless things.

1 Comment

Filed under Funding

Thomas Perls – Increasing Genetic Influence Upon Exceptional Longevity with Older and Older Ages

Here’s a talk by Dr. Thomas Perls at the 2nd Genetics of Aging and Longevity Conference. Dr. Thomas Perls, MD, MPH, Associate Professor, Boston University Medical Center,  is the founder and director of the New England Centenarian Study, the largest study of centenarians in the world. A significant portion of the study is devoted to understanding why centenarians delay or escape Alzheimer’s disease and other brain disorders.

Leave a Comment

Filed under Conference

Claudio Franceschi – High Throughput Technologies (OMICS) as a New Tool to Identify Biomarkers of Longevity and Healthy Aging

Enjoy the plenary talk by Dr. Claudio Franceschi, PRofessor at the University of Bologna, one of the best specialists on aging of the immune system and biomarkers of aging.

1 Comment

Filed under Conference

Judy Campisi – Cancer and Aging: Rival Demons?

Enjoy Judy Campisi’s plenary talk about the relationship between aging and cancer.

Leave a Comment

Filed under Conference